161 related articles for article (PubMed ID: 14693316)
21. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
[TBL] [Abstract][Full Text] [Related]
22. Need for care and perceptions of MIDAS among headache sufferers study.
Stewart W; Lipton R
CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034
[TBL] [Abstract][Full Text] [Related]
23. Functional Assessment in Migraine (FAIM) questionnaire: development of an instrument based upon the WHO's International Classification of Functioning, Disability, and Health.
Pathak DS; Chisolm DJ; Weis KA
Value Health; 2005; 8(5):591-600. PubMed ID: 16176497
[TBL] [Abstract][Full Text] [Related]
24. Validation of the revised Patient Perception of Migraine Questionnaire (PPMQ-R): measuring satisfaction with acute migraine treatment in clinical trials.
Kimel M; Hsieh R; McCormack J; Burch SP; Revicki DA
Cephalalgia; 2008 May; 28(5):510-23. PubMed ID: 18384420
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
[TBL] [Abstract][Full Text] [Related]
26. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
27. Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study.
Houts CR; McGinley JS; Wirth RJ; Cady R; Lipton RB
Qual Life Res; 2021 Mar; 30(3):931-943. PubMed ID: 33079313
[TBL] [Abstract][Full Text] [Related]
28. Reliability, validity, and clinical utility of the Migraine-ACT questionnaire.
Kilminster SG; Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D
Headache; 2006 Apr; 46(4):553-62. PubMed ID: 16643548
[TBL] [Abstract][Full Text] [Related]
29. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
30. Global trends in migraine care: results from the MAZE survey.
Brandes JL
CNS Drugs; 2002; 16 Suppl 1():13-8. PubMed ID: 12196035
[TBL] [Abstract][Full Text] [Related]
31. Psychometric properties of a standardized-patient checklist and rating-scale form used to assess interpersonal and communication skills.
Cohen DS; Colliver JA; Marcy MS; Fried ED; Swartz MH
Acad Med; 1996 Jan; 71(1 Suppl):S87-9. PubMed ID: 8546794
[TBL] [Abstract][Full Text] [Related]
32. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
Colman SS; Brod MI; Krishnamurthy A; Rowland CR; Jirgens KJ; Gomez-Mancilla B
Clin Ther; 2001 Jan; 23(1):127-45. PubMed ID: 11219473
[TBL] [Abstract][Full Text] [Related]
33. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
Kawata AK; Hsieh R; Bender R; Shaffer S; Revicki DA; Bayliss M; Buse DC; Desai P; Sapra S; Ortmeier B; Hareendran A
Headache; 2017 Oct; 57(9):1385-1398. PubMed ID: 28857154
[TBL] [Abstract][Full Text] [Related]
34. Back pain management in primary care: development and validity of the Patients' and Doctors' Expectations Questionnaire.
Georgy EE; Carr EC; Breen AC
Qual Prim Care; 2013; 21(2):113-22. PubMed ID: 23735692
[TBL] [Abstract][Full Text] [Related]
35. Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, Short-Form McGill Pain Questionnaire, and patients' perspectives.
Truong PT; Abnousi F; Yong CM; Hayashi A; Runkel JA; Phillips T; Olivotto IA
Plast Reconstr Surg; 2005 Oct; 116(5):1291-9. PubMed ID: 16217470
[TBL] [Abstract][Full Text] [Related]
36. Global assessment of migraine severity measure: preliminary evidence of construct validity.
Sajobi TT; Amoozegar F; Wang M; Wiebe N; Fiest KM; Patten SB; Jette N
BMC Neurol; 2019 Apr; 19(1):53. PubMed ID: 30947702
[TBL] [Abstract][Full Text] [Related]
37. Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment.
Cole JC; Lin P; Rupnow MF
Qual Life Res; 2007 Sep; 16(7):1231-7. PubMed ID: 17468941
[TBL] [Abstract][Full Text] [Related]
38. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
39. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.
Lofland JH; Johnson NE; Batenhorst AS; Nash DB
Arch Intern Med; 1999 Apr; 159(8):857-63. PubMed ID: 10219932
[TBL] [Abstract][Full Text] [Related]
40. Crosscultural Adaptation and Validation of the Korean Version of the New Knee Society Knee Scoring System.
Kim SJ; Basur MS; Park CK; Chong S; Kang YG; Kim MJ; Jeong JS; Kim TK
Clin Orthop Relat Res; 2017 Jun; 475(6):1629-1639. PubMed ID: 28265885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
